Heart trial success will give Xarelto edge
Xarelto aces outcomes trial and could have edge over Boehringer and BMS rivals.
X
Heart trial success will give Xarelto edge
https://pharmaphorum.com/news/janssenbayer-take-aim-rival-noacs-trial-success/
Xarelto aces outcomes trial and could have edge over Boehringer and BMS rivals.